<DOC>
	<DOCNO>NCT02596802</DOCNO>
	<brief_summary>The goal study feasibility safety implement Fetoscopic Endoluminal Tracheal Occlusion ( FETO ) therapy fetus severe leave Congenital Diaphragmatic Hernia ( CDH ) . The pilot study determine whether FETO therapy perform safely whether increase survival decrease morbidity compare standard prenatal care treatment severe leave CDH .</brief_summary>
	<brief_title>Fetoscopic Endoluminal Tracheal Occlusion ( FETO ) Congenital Diaphragm Hernia</brief_title>
	<detailed_description />
	<mesh_term>Hernia</mesh_term>
	<mesh_term>Hernia , Diaphragmatic</mesh_term>
	<mesh_term>Hernias , Diaphragmatic , Congenital</mesh_term>
	<criteria>1 . Pregnant woman age 18 year old 2 . Singleton pregnancy 3 . Normal fetal karyotype confirmation culture result . Results fluorescence situ hybridization ( FISH ) acceptable patient &gt; 26 week 4 . Isolated Left CDH liver 5 . Gestation age enrollment prior 29 wks plus 6 day 6 . SEVERE pulmonary hypoplasia US O/E lung head ratio ( LHR ) &lt; 25 % ( measure 18 week 0 day 29 week 5 day ) time surgery 7 . Gestational age FETO procedure 27 week 0 day 29 week 6 day determine clinical information ( LMP ) evaluation first ultrasound 8 . Patient meet psychosocial criterion 9 . Informed consent 1 . Patient &lt; 18 year age 2 . Multifetal pregnancy 3 . History natural rubber latex allergy 4 . Preterm labor , cervix shorten ( &lt; 15 mm enrollment within 24 hour FETO balloon insertion procedure ) uterine anomaly strongly predispose preterm labor , placenta previa 5 . Psychosocial ineligibility , preclude consent : Inability reside within 30 minute The Fetal Center Children 's Memorial Hermann Hospital . inability comply travel followup requirement trial Patient support person ( e.g . spouse , partner , mother ) available stay patient duration pregnancy The Fetal Center Children 's Memorial Hermann Hospital . 6 . Right side CDH bilateral CDH , isolate left side O/E LHR â‰¥25 % ( measure 18 week 0 day 29 week 5 day ) determine ultrasound [ 1 ] 7 . Additional fetal anomaly chromosomal abnormality ultrasound , MRI , echocardiogram fetal treatment center . No case remove post hoc abnormality discover course postoperative monitoring 8 . Maternal contraindication fetoscopic surgery severe maternal medical condition pregnancy 9 . History incompetent cervix without cerclage 10 . Placental abnormality ( previa , abruption , accrete ) know time enrollment 11 . Maternalfetal Rh isoimmunization , Kell sensitization neonatal alloimmune thrombocytopenia affect current pregnancy 12 . Maternal HIV , HepatitisB , HepatitisC status positive increase risk transmission fetus maternalfetal surgery . If patient 's HIV Hepatitis status unknown , patient must test found negative result enrollment 13 . Uterine anomaly large multiple fibroid mullerian duct abnormality 14 . There safe technically feasible fetoscopic approach balloon placement 15 . Participation another intervention study influence maternal fetal morbidity mortality participation trial previous pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Fetoscopic Endoluminal Tracheal Occlusion</keyword>
	<keyword>Congenital Diaphragmatic Hernia</keyword>
</DOC>